Mexico signs deal for Oxford's Covid-19 vaccine

PanArmenian.Net
14 Aug 2020, 23:37 GMT+10

PanARMENIAN.Net - A potential coronavirus vaccine developed by the Oxford University will be produced in Mexico if its advanced trials are successful and it receives regulatory approval as cases in the country surpassed half a million, Al Jazeera says.

President Andres Manuel Lopez Obrador said the agreement with pharmaceutical company AstraZeneca, which also provides for production in Argentina, should result in a vaccine that the government would provide free starting in the first quarter of 2021.

He said on Thursday, August 13 access to the vaccine would be 'universal and free' in Mexico, which has registered nearly 55,000 coronavirus deaths - the third-highest toll in the world behind the United States and Brazil.

'In other countries, they can decide to charge or select who is vaccinated and who not, but so there isn't any doubt and to guarantee to all our people, all Mexicans are going to have access to the vaccine,' Lopez Obrador said at a news conference.

Production of the vaccine in Mexico and Argentina would allow for distribution throughout Latin America, except for Brazil, which had already reached its own agreement with the drugmaker.

AstraZeneca said the agreement covers an initial production of 150 million doses for the region, with the possibility of increasing to 400 million doses. Production will be funded by the foundation of Mexican mogul Carlos Slim, once the world's richest man.

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Caribbean Herald.

More Information

null in null

Business

Section

US consumers cut back after early surge ahead of Trump tariffs

US retail sales drop in May amid post-tariff spending slowdown

WASHINGTON, D.C.: Retail sales dropped sharply in May as consumer spending slowed after a strong start to the year, primarily due to...

Mitsubishi joins automakers raising prices after import tariffs

Mitsubishi to hike U.S. car prices 2.1% amid Trump tariffs

WASHINGTON, D.C.: Mitsubishi Motors is the latest automaker to raise prices in the United States, joining a growing list of car companies...

Lilly makes $1.3 billion move to expand into gene-edited heart drugs

Lilly to buy Verve for $1.3 billion in heart gene therapy expansion

INDIANAPOLIS, Indiana: Eli Lilly is making a bold play in cardiovascular gene therapy, announcing plans to acquire its partner Verve...

New Zealand PM seeks stronger ties with China amid security talks

New Zealand PM Luxon in China to boost trade and tourism

BEIJING/WELLINGTON: New Zealand's Prime Minister Christopher Luxon commenced his visit to China on June 17, seeking to strengthen trade...

U.S. on edge as Israel-Iran conflict escalates

Dow Jones drops 44 points as Wall Street takes a breather

NEW YORK, New York - U.S. stocks made only minor moves in both directions,Thursday, as investors fretted about the Israel-Iran conflict...

Luxury giant Kering bets on outsider de Meo to lead turnaround

Kering picks Renault's de Meo to fix Gucci, slash soaring debt

PARIS, France: Luxury group Kering's decision to tap Luca de Meo as its next chief is being seen as a daring but necessary attempt...

Latin America

Section